Haemonetics Corp
NYSE:HAE
Haemonetics Corp
NYSE:HAE
Price:
95.2 USD
-0.19%
Market Closed
Updated:
May 8, 2024
Haemonetics Corp
Revenue
|
Haemonetics Corp
Revenue Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haemonetics Corp
NYSE:HAE
|
Revenue
$1.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$3.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Revenue
$1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
31%
|
CAGR 10-Years
17%
|
Haemonetics Corp
Revenue Breakdown
Breakdown by Geography
Haemonetics Corp
Haemonetics Corp
|
Total Revenue:
1.2B
USD
|
|
United States:
842.9m
USD
|
|
Europe:
156.7m
USD
|
|
Asia:
104.1m
USD
|
|
Japan:
61.3m
USD
|
|
Other Country Or Region:
3.7m
USD
|
Breakdown by Segments
Haemonetics Corp
Haemonetics Corp
|
Total Revenue:
1.2B
USD
|
|
Plasma:
563.7m
USD
|
|
Hospital:
378.1m
USD
|
|
Blood Center:
226.8m
USD
|
|
Service:
21.4m
USD
|
See Also
What is Haemonetics Corp's Revenue?
Revenue
1.3B
USD
1.3B
USD
Based on the financial report for Dec 30, 2023, Haemonetics Corp's Revenue amounts to 1.3B USD.
What is Haemonetics Corp's Revenue growth rate?
Revenue CAGR 10Y
3%
3%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Haemonetics Corp have been 13% over the past three years , 6% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
